Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$16,437,879
+$203,556 QoQ
Shares Held
65,323
-12.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
3.39%
of 13F equity value
Holder Rank
#697
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DUNCKER STREETT & CO INC holds $39,564,499 across 8 Drug Manufacturers - General names. ABBV ranks #1 (41.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
65,323 | $16,437,879 | |
| 2 | MRK |
Merck & Co., Inc.
|
67,296 | $8,647,536 | |
| 3 | LLY |
ELI LILLY & Co
|
5,580 | $6,692,819 | |
| 4 | JNJ |
Johnson & Johnson
|
15,138 | $3,844,597 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
36,580 | $2,107,739 | |
| 6 | AMGN |
Amgen Inc
|
3,175 | $1,149,731 | |
| 7 | PFE |
Pfizer Inc
|
24,821 | $597,689 | |
| 8 | NVS |
Novartis AG
|
552 | $86,509 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,437,879 | 65,323 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $16,234,323 | 74,644 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $16,454,021 | 72,012 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $16,503,476 | 71,277 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $11,240,404 | 60,556 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $12,602,208 | 60,148 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $7,923,465 | 44,589 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $8,866,852 | 44,900 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,703,649 | 44,914 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $8,128,215 | 44,636 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $7,069,576 | 45,619 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $6,815,023 | 45,720 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $6,169,556 | 45,792 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $7,333,729 | 46,017 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $7,593,892 | 46,989 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $6,316,996 | 47,068 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $7,213,070 | 47,095 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $7,716,760 | 47,602 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $7,104,979 | 52,474 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $5,647,749 | 52,357 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $5,734,051 | 50,906 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $5,500,173 | 50,824 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $5,413,539 | 50,523 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $4,330,624 | 49,442 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $4,845,575 | 49,354 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $3,923,937 | 51,502 | Shares | Other | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||